IRCT20200407046981N49尚未招募未知
Comparative bioequivalence study of the Penicillamine 250-mg Capsules manufactured by Vana Darou Gostar Company with Penicillamine brand capsules (Cupripen®) by Laboratorios Rubio company
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- Male
入选标准
- •The weight limit of each volunteer should be between 60 and 100 kg.
- •All volunteers must be non-smokers.
- •They must be healthy in terms of liver, kidney, respiratory system, mental and other general health characteristics that will be assessed.
- •Candidates who have consented to the consent form.
排除标准
- •Known hypersensitivity or idiosyncratic reaction to Penicillamine or any ingredients.
- •Subjects with BP = 90/60 mm/Hg or BP = 140/90 mm/Hg.
- •Taking any medicine during two week before dosing
研究者
相似试验
尚未招募
不适用
Study of absorption and elimination rate of Linagliptin tablets 5 mg in comparison with Linagliptin brand tablets (Tradjenta®).Bioequivalence study.IRCT20200407046981N37Darmanyab darou pharmaceutical company24
招募中
不适用
Bioequivalency study of two different Metformin formulationsIRCT20111107008022N7Reihaneh Pharmaceutical Company24
尚未招募
Unknown
Bioequivalence study of two different Ciprofloxacin formulationsIRCT20111107008022N13Zagrous Darou Pharmaceutical Company24
尚未招募
不适用
Bioequivalence study of two different Fenofibrate formulationsIRCT20111107008022N10Aviccena Pharmaceutical Company24
招募中
不适用
Bioequivalency study of two different Pantoprazole formulationsHealth volunteers.IRCT20111107008022N8Exir Pharmaceutical Company24